Fundz

Recursion Pharmaceuticals, Inc. reported raising $122 Million in an initial SEC Form D filing, from an offering of $122 Million

PUBLIC · RXRXAug 13, 2019

Amount Raised

$122 Million

$122 Million sold, per SEC Form D (first sale Aug 13, 2019)

Round Type

Venture

Salt Lake CityBiotechnologyHealthcareHealth CareArtificial IntelligenceTherapeuticsPharmaceutical

Quick answer

Recursion Pharmaceuticals raised $122 Million in a funding round, dated August 13, 2019. Recursion Pharmaceuticals is based in Salt Lake City, Utah, United States.

How much did Recursion Pharmaceuticals raise?
Recursion Pharmaceuticals raised $122 Million in a funding round on August 13, 2019.
What does Recursion Pharmaceuticals do?
Recursion Pharmaceuticals, Inc. is a biotechnology company that leverages advanced technology to discover and develop potential new drugs.
Where is Recursion Pharmaceuticals based and how big is it?
Recursion Pharmaceuticals is based in Salt Lake City, Utah, United States. Fundz records about 800 employees.
Who are the decision-makers at Recursion Pharmaceuticals?
Fundz holds 1 contact at Recursion Pharmaceuticals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Recursion Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • vTv Therapeutics Inc. raised $4M (Seed) on July 9, 2019.
  • Renibus Therapeutics raised $3.4M on September 23, 2019.
  • OnKure Therapeutics raised $100K (Seed) on September 20, 2019.
  • CUREMARK LLC raised $5.4M on September 11, 2019.
  • Passage Bio raised $110M on September 6, 2019.
  • Landos Biopharma, Inc. raised $60M on August 23, 2019.

Who to call at Recursion Pharmaceuticals, and when

A new round usually means Recursion Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Recursion Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Recursion Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Recursion Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Recursion Pharmaceuticals

Location

41S Rio Grande Street

Salt Lake City, Utah, United States

About

Recursion Pharmaceuticals, Inc. is a biotechnology company that leverages advanced technology to discover and develop potential new drugs. The company focuses on therapeutics in disease areas with significant unmet medical need. Through its innovative platform, Recursion aims to transform the process of drug discovery. With a commitment to improving patient outcomes, the company is at the forefront of using data-driven approaches in medicine.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Recursion Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts53 people are listed at Recursion Pharmaceuticals. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Recursion Pharmaceuticals's next move

See what Strategic adds

Recursion Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.